Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
103831701000001118 | Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
103831801000001110 | Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd) 50 capsule | Is a | True | Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule | Inferred relationship | Existential restriction modifier | |
MagnEss Gly 48.6mg (2mmol) capsules (Essential-Healthcare Ltd) 50 capsule | Is a | True | Magnesium glycerophosphate (magnesium 48.6mg (2mmol)) capsules 50 capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets